News Release

AI serves as ‘crystal ball’ for predicting outcomes in hospitalized cirrhosis patients

New study finds machine learning outperforms traditional methods in prioritizing treatment for patients with cirrhosis

Peer-Reviewed Publication

American Gastroenterological Association

Machine learning to improve inpatient cirrhosis mortality predictions

image: 

A study used machine learning to predict outcomes for hospitalized cirrhosis patients.

view more 

Credit: Gastroenterology

Bethesda, MD (July 18, 2025) — Researchers employed a machine learning technique known as random forest analysis and found that it significantly outperformed traditional methods in predicting which hospitalized patients with cirrhosis are at risk of death, according to a new paper published in Gastroenterology.

“This gives us a crystal ball — it helps hospital teams, transplant centers, GI and ICU services to triage and prioritize patients more effectively,” said Dr. Jasmohan S. Bajaj, the study's corresponding author. 

Key findings:

  • Data analyzed from 121 hospitals worldwide, which were part of the CLEARED consortium.
  • The model performed consistently across both high- and low-income countries.
  • It was validated using National U.S. veterans’ data and remained accurate.
  • The tool maintained strong performance even when limited to just 15 key variables.
  • Patients were accurately grouped into high-risk and low-risk categories, making the model scalable and clinically practical. 

Explore the model in action here: https://silveys.shinyapps.io/app_cleared/. 

This paper is one of three studies recently published on this topic in the American Gastroenterological Association’s journals. One was a worldwide consensus statement on organ failures, including liver in cirrhosis patients, while the second study identified specific blood markers and complications that influence the risk of in-hospital death, focusing on liver failure biomarkers. 

“Liver disease is one of the most underappreciated causes of death worldwide — alcohol, viral hepatitis, and late diagnoses are major drivers,” Bajaj said. “When someone is hospitalized, it’s often because everything upstream — prevention, screening, primary care — has already failed.”

Contact for media: Annie Mehl, media@gastro.org, 301-272-0013 

About the AGA Institute 
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization. www.gastro.org 

AGA is on Instagram
Like AGA on Facebook. 
Follow us on X @AmerGastroAssn and Bluesky @amergastroassn.bsky.social
Check out our videos on YouTube
Join AGA on LinkedIn


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.